Study on the Efficacy and Appropriateness of Various Treatment Methods for Primary Thyroid Lymphoma Using Tokyo Cancer Registry Data

Study on the Efficacy and Appropriateness of Various Treatment Methods for Primary Thyroid Lymphoma Using Tokyo Cancer Registry Data - Tokyo Thyroid Lymphoma Research (TTLR)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055521

Enrollment

300

Registered

2024-09-17

Start date

2024-09-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Thyroid Lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients registered in the Tokyo Cancer Registry between 2012 and 2020, with ICD-O3 code C739 and excluding ICD-10 code C73.

Exclusion criteria

Exclusion criteria: Cases with a histological diagnosis other than primary thyroid lymphoma, or cases with a survival time of 0 days from the date of diagnosis.

Design outcomes

Primary

Measure	Time frame
Overall survival (OS)	—

Secondary

Measure	Time frame
Disease-specific survival and 90-day mortality from diagnosis.	—

Countries

Japan

Contacts

Public ContactYoshiyuki Saito

Ito hospital Department of Surgery

y-saito@ito-hospital.jp+81-3-3402-7411

Outcome results